Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | Corporate Executive VP | May 29, 2020 | June 02, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date May 29, 2020 · Filed June 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 224,478 |
Reported balance
After 2020-05-29 transaction · row 1
1 source rowRow 1 · 2020-05-29 · Grant · Acquired 557 · Balance 224,478 F1: Unvested restricted stock units vest as follows: 278 on May 29, 2021 and 279 on May, 29 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Unvested restricted stock units vest as follows: 278 on May 29, 2021 and 279 on May, 29 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 29, 2020 Filed Jun 2, 2020 21:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 557 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018493 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,478 F1 · shares: Unvested restricted stock units vest as follows: 278 on May 29, 2021 and 279 on May, 29 2022. Read SEC document |
| February 26, 2020 Filed Feb 26, 2020 17:24 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 727 | $162.46 | $118,108.42 |
DisclosureSEC source: 0001127602-20-007865 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,921 Read SEC document |
| February 24, 2020 Filed Feb 24, 2020 17:18 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 710 | $173.64 | $123,284.40 |
DisclosureSEC source: 0001127602-20-007119 · form4.xml · nonDerivative · entry 3 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,648 Read SEC document |
| February 23, 2020 Filed Feb 24, 2020 17:18 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 862 | $173.64 | $149,677.68 |
DisclosureSEC source: 0001127602-20-007119 · form4.xml · nonDerivative · entry 2 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,358 Read SEC document |
| February 22, 2020 Filed Feb 24, 2020 17:18 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 770 | $173.64 | $133,702.80 |
DisclosureSEC source: 0001127602-20-007119 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,220 Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 20:37 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 9,592 | $159.07 | $1,525,799.44 |
DisclosureSEC source: 0001127602-20-004564 · form4.xml · nonDerivative · entry 2 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,990 Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 20:37 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 23,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004564 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,582 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 24, 2017. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 24,660 | $0.00 Strike: $76.67 | $0.00 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · derivative · entry 31 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,660 shares Expires 2020-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 237 | $145.90 | $34,578.30 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 30 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,854 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 10 | $145.47 | $1,454.70 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 29 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,091 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 103 | $145.46 | $14,982.38 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 28 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,101 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 23 | $145.26 | $3,340.98 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 27 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,204 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 77 | $145.23 | $11,182.71 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 26 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,227 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $145.22 | $58,088.00 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 25 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,304 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 64 | $145.17 | $9,290.88 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 24 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,704 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 58 | $145.16 | $8,419.28 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 23 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,768 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 52 | $145.15 | $7,547.80 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 22 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,826 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 221 | $145.14 | $32,075.94 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 21 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,878 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 553 | $145.13 | $80,256.89 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 20 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,099 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 3,113 | $145.00 | $451,385.00 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 19 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,652 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 58 | $144.71 | $8,393.18 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 18 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,765 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 53 | $144.70 | $7,669.10 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 17 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,823 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 157 | $144.69 | $22,716.33 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 16 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,876 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $144.68 | $14,468.00 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 15 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,033 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 532 | $144.67 | $76,964.44 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 14 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,133 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 101 | $144.52 | $14,596.52 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 13 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,665 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 214 | $144.41 | $30,903.74 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 12 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,766 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 75 | $144.40 | $10,830.00 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 11 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,980 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $144.25 | $28,850.00 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 10 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,055 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,100 | $144.24 | $158,664.00 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 9 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,255 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 2,400 | $144.23 | $346,152.00 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 8 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,355 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,400 | $144.22 | $201,908.00 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 7 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,755 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 700 | $144.21 | $100,947.00 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 6 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,155 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 957 | $144.00 | $137,808.00 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 5 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,855 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 543 | $143.82 | $78,094.26 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 4 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,812 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 10,959 | $143.81 | $1,576,013.79 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 3 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,355 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $143.80 | $28,760.00 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 2 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,314 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 15:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 24,660 | $76.67 | $1,890,682.20 |
DisclosureSEC source: 0001127602-19-034723 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Feb 28, 2019 14:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 621 | $140.71 | $87,380.91 |
DisclosureSEC source: 0001127602-19-008796 · form4.xml · nonDerivative · entry 2 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,854 Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 14:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 728 | $145.31 | $105,785.68 |
DisclosureSEC source: 0001127602-19-008796 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,475 Read SEC document |
| February 24, 2019 Filed Feb 26, 2019 19:43 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 980 | $144.67 | $141,776.60 |
DisclosureSEC source: 0001127602-19-008316 · form4.xml · nonDerivative · entry 4 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,203 Read SEC document |
| February 23, 2019 Filed Feb 26, 2019 19:43 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 863 | $144.67 | $124,850.21 |
DisclosureSEC source: 0001127602-19-008316 · form4.xml · nonDerivative · entry 3 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,183 Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 19:43 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 22,819 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001127602-19-008316 · form4.xml · derivative · entry 5 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,819 Underlying: Common Stock · 22,819 shares Expires 2024-02-22 F3 · derivative.exercise_date: Stock options vest as follows: 5,704 options vest one (1) year from the date of grant, 5,705 options vest two (2) years from the date of grant, 5,705 options vest three (3) years from the date of grant, and 5,705 options vest four (4) years from the date of grant. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 19:43 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 5,352 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-008316 · form4.xml · nonDerivative · entry 2 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,046 F2 · security: Consists of 5,352 unvested restricted stock units that vest equally over four (4) years beginning one (1) year from the date of issuance. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 19:43 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 793 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-008316 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,694 F1 · security: Consists of 793 unvested restricted stock units that vest as follows: 396 shares vest one (1) year from the date of grant, and 397 shares vest two (2) years from the date of grant. Read SEC document |
| January 30, 2019 Filed Feb 1, 2019 18:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 8,486 | $119.39 | $1,013,143.54 |
DisclosureSEC source: 0001127602-19-003326 · form4.xml · nonDerivative · entry 2 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,901 Read SEC document |
| January 30, 2019 Filed Feb 1, 2019 18:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 21,894 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-003326 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,387 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 26, 2016. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 18:29 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 23,356 | $0.00 Strike: $59.41 | $0.00 |
DisclosureSEC source: 0001127602-18-032479 · form4.xml · derivative · entry 3 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,356 shares Expires 2021-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 18:29 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 23,356 | $136.00 | $3,176,416.00 |
DisclosureSEC source: 0001127602-18-032479 · form4.xml · nonDerivative · entry 2 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,493 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 18:29 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 23,356 | $59.41 | $1,387,579.96 |
DisclosureSEC source: 0001127602-18-032479 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.